Latest News — Page 82

A recent update has been published by NICE (National Institute for Health and Care Excellence). It described the use of artificial intelligence (AI)-derived software in analysing chest X-rays for suspected lung cancer. This has been under scrutiny in primary care referrals. This initiative is part of the NHS’s ambition to diagnose 75% of all cancers at stages 1 or 2 by 2028. Potential Benefits of AI-Derived Software in Chest X-Ray Analysis The AI-equipped software can detect lung abnormalities in chest […]

The Challenges of Substandard Medical Products Substandard and falsified (SF) medical products pose a significant threat to public health. These products can cause harm, fuel resistance to genuine treatments, and undermine health systems. In Francophone sub-Saharan Africa, SF products are increasingly prevalent, largely due to the limited capacity of National Regulatory Authorities (NRAs) to fulfil their functions. Solutions and Initiatives Several initiatives are helping to combat this issue. The African Union (AU) and the World Health Organization (WHO) have launched […]

Value-based medicine, or VBM, is changing healthcare management worldwide by introducing innovative methods to reduce costs and enhance patients’ health. VBM aims to optimise medical treatments by considering their clinical, social, and financial outcomes, rather than merely reducing costs. One area where the impact of VBM can be observed is in the care of individuals who have suffered from a stroke. The increasing prevalence of elderly and people with chronic diseases places more strain on healthcare infrastructure. With the increasing […]

According to a new study, the United States wastes $1 trillion a year on healthcare. The staggering cost of inefficiency is higher than the world’s 17th-biggest country’s GDP. Waste in healthcare affects patient care, the speed of organisations, and the cost of materials. Mistakes and wasteful spending are more likely in the healthcare system due to its complexity. This severely reduces the effectiveness of treatment. Value-based care methods were created to deal with this issue. They promote cost-effective clinical results […]

Unifying Efforts for Digital Health Ecosystem Globally Abu Dhabi Global Healthcare Week (ADGHW) has partnered with Digital Health New York (DHNY) to enhance the global digital health ecosystem. The Memorandum of Understanding (MoU), signed on October 4, 2023, aims to promote collaboration, innovation, long-term investment, and knowledge exchange in the digital health sector. The two-year partnership will focus on developing research and innovation in digital health, enhancing credibility in science, and providing access to subject-matter experts through open dialogue. Tackling […]

A New Class IA Recommendation for Heart Failure Treatment Heart failure, a major cause of hospital admissions in the U.S., comes with high morbidity, mortality, and financial costs. Recent advances in pharmacotherapy for heart failure with reduced ejection fraction (HFrEF) have given rise to new disease-modifying therapies. One such novel angiotensin receptor neprilysin inhibitor (ARNI) is sacubitril-valsartan. The PARADIGM-HF clinical trial found that sacubitril-valsartan reduced the risk of cardiovascular death or hospitalization due to heart failure (HF), among ambulatory patients […]

In healthcare, artificial intelligence has made considerable strides. It has the potential to enhance prediction, diagnosis, and decision-making. Researchers in orthopaedic surgery, where AI technologies have the potential to alter the discipline, have also seen this. They can apply artificial intelligence in orthopaedics to find trends in data. Predicting patient risk potential or bad occurrences, for example, offers clinicians with crucial information. Despite the label “experimental,” there is mounting evidence that AI is successful and suitable for widespread use. AI […]

The Inflation Reduction Act (IRA) has initiated a new era in drug pricing. Soon, the Centers for Medicare & Medicaid Services (CMS) in the U.S will negotiate prices for certain high-cost drugs. This includes direct-acting oral anticoagulants (DOACs) apixaban (Eliquis) and rivaroxaban (Xarelto). These were among the first 10 drugs selected for negotiation. Clinical and Economic Comparisons The Institute for Clinical and Economic Review (ICER) released a Special Report that examines these two drugs, primarily used for non-valvular atrial fibrillation […]

A Collaborative Approach to Diabetes Care A recent study has shown that clinical pharmacists, in collaboration with health coaches, are making a significant impact on diabetes management and cardiovascular disease risk reduction. They provide comprehensive medication management, addressing adverse effects and drug interactions, assisting in medication taking, and intensifying therapy. The study also highlighted the importance of collaborative action with physicians in improving patient outcomes. Innovative Methods for Effective Diabetes Management The study deployed innovative methods to achieve effective diabetes […]

A New Era in Melanoma Treatment The landscape of treating stage III and IV malignant melanoma (MM), one of the most aggressive skin cancers, has drastically transformed over the past decade. The introduction of immune checkpoint inhibitors (ICIs) such as ipilimumab (IPI) and nivolumab (NIVO) has revolutionized melanoma treatment, offering increased overall survival rates compared to traditional chemotherapy. The Rise of Combination Therapies The development and approval of combination therapies have further enhanced treatment effectiveness. These therapies, which combine two […]

Artificial Intelligence (AI) has been a game-changer in many sectors, including healthcare. AI has been successful in Assistive Technology, an area that’s always been at the forefront of technology. AI has the potential to revolutionize AT, as highlighted by the UN Special Rapporteur on the rights of persons with disabilities. It can enhance assistive robots, autonomous wheelchairs, and guidance systems for visually impaired individuals. Speech recognition improvements are improving AT applications, while smart homes can boost independence and well-being. However, […]

First 10 Drugs Announced for Medicare Price Negotiation On August 29, 2023, the Biden-Harris administration revealed the first 10 drugs chosen for Medicare price negotiation under the Inflation Reduction Act (IRA). Five of these drugs treat cardiovascular conditions such as atrial fibrillation and heart failure. This is a significant step towards improving access to lifesaving therapies for cardiovascular conditions that affect millions of older US residents. The rising prevalence of cardiovascular and metabolic diseases in the elderly (65 years and […]

Oracle, an IT company, has been making recent waves within the healthcare space. In late 2021, Oracle announced its plans to acquire Cerner, a digital information systems provider whose software hospitals use. The deal concluded a year later, in 2022, which saw Oracle take a share of the healthcare market in the Electronic Health Record space. This is because of Cerner’s already established presence. The US has had a strong focus on healthcare services. The HITECH Act introduced an important […]

Introduction to the ACTFAST-3 Study The Anesthesiology Control Tower (ACT), a real-time telemedicine decision support system, was tested in the ACTFAST-3 Randomised Clinical Trial. The study aimed to evaluate the feasibility of the ACT and its impact on two quality of care measures: postoperative hypothermia and hyperglycemia. The ACTFAST-3 study, a single-centre pilot superiority RCT, took place in the USA from April 2017 to June 2019. The study involved all patients aged 18 years and above who had undergone surgery. […]

In the rapidly evolving landscape of healthcare, the concept of collaborative intelligence is emerging as a transformative force. The new approach uses AI and human learning to improve patient care, which is a promising future for healthcare. Collaborative intelligence strives to enhance outcomes through collective data interpretation, a stark contrast to the human-in-the-loop (HITL) approach, which leverages both AI and human collaboration for quick algorithm development. This technology has already significantly transformed areas like radiology, and it will further integrate […]

The English National Institute for Health and Care Excellence (NICE) is a key player in Health Technology Assessment (HTA) worldwide. A report from the Office of Health Economics (OHE) explored NICE’s decision outcomes and their effects on HTA in 12 other countries. Data showed that NICE decisions are issued relatively quickly, often favouring positive outcomes. However, NICE frequently issued “optimised decisions,” recommendations for using an intervention in a smaller population than licensed but with more favourable cost-effectiveness evidence. The report […]